Singapore markets closed

DexCom Inc (DC4.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
105.96-2.84 (-2.61%)
At close: 08:08AM CEST
Full screen
Previous close108.80
Open105.96
Bid108.20 x 0
Ask108.42 x 0
Day's range105.96 - 105.96
52-week range71.33 - 130.22
Volume30
Avg. volume2
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Dexcom G7 Now Connects Directly to Apple Watch in the U.S.

    SAN DIEGO, June 05, 2024--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the Dexcom G7 Continuous Glucose Monitoring (CGM) System now connects directly to Apple Watch* in the United States. Dexcom G7 is the first and only CGM available with Direct to Apple Watch, offering users the freedom and convenience of real-time glucose readings on their wrist even when their iPhone isn’t with them.†

  • Business Wire

    Dexcom Wins Access to Dexcom ONE for 100,000 People Living With Type 2 Diabetes

    EDINBURGH, Scotland, June 04, 2024--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant advancement in access to its products for those treating Type 2 diabetes (T2D) with basal insulin injections. The company, which pioneered CGM technology 25 years ago, has secured access to its Dexcom ONE sensor for around 100,000 T2D users in France. The reimbursement guidance offers people aged over two years who are

  • Business Wire

    Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems

    BURNABY, British Columbia, June 03, 2024--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, today announced that residents of Nova Scotia living with either type 1 or type 2 diabetes who use intensive insulin and meet eligibility criteria now have coverage for Dexcom G6 and Dexcom G7 continuous glucose monitoring (CGM) systems.